Form 4 for OMCL OMNICELL, INC.
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001415889-22-012075 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-05 | 2022-12-01 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | S - Sale+OE | $50.78 | -2,500 | 88.3K | -3% | -$126.9K |
| D | 2022-12-05 | 2022-12-01 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | M - OptEx | $17.29 | +2,500 | 90.8K | +3% | +$43.2K |
| D | 2022-12-05 | 2022-12-01 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | M - OptEx | $0.00 | -2,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | S | D | 1,600 | $50.49 | 89,248 | D | — | — | (F1) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. (F3) The price reported in Column 4 is a weighted average price of $50.4888. The sold price range between $49.97 to $50.92. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2022-12-01 | S | D | 900 | $51.29 | 88,348 | D | — | — | (F1) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. (F4) The price reported in Column 4 is a weighted average price of $51.2889. The sold price range between $50.98 to $51.77. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-12-01 | M | A | 2,500 | $17.29 | 90,848 | D | — | — | (F1) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. (F2) The balance is adjusted to reflect 211 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/22. |
| 4 | Derivative | Stock Option NQ (Right to Buy) | 2022-12-01 | M | D | 2,500 | $0.00 | 0 | D | $17.29 · 2017-02-05 to 2023-02-04 | 2,500 Common Stock | (F1) This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2021. |